Association of DRD2 gene variant with schizophrenia

Schizophrenia is a complex multifactorial disorder for which the pathobiology still remains elusive. Dysfunction of the dopamine D2 receptor signaling has been associated with the illness, but numerous studies provide confounding results. This study investigates the association of synonymous polymorphisms (His313 and Pro319) in the dopamine D2 receptor gene with schizophrenia using a case-control approach, with 101 cases and 145 controls. Our results demonstrated that genotype distribution for the His313 polymorphism was significantly different between schizophrenia patients and control subjects (p=0.0012), while the Pro319 polymorphism did not show any association with the disease. The results suggest that the synonymous SNP His313 in DRD2 may be associated with the illness. However, there is a need for further replication studies with larger sample sets.

[1]  J. Basilion,et al.  Single-nucleotide polymorphisms can cause different structural folds of mRNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Itokawa,et al.  A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys). , 1993, Biochemical and biophysical research communications.

[3]  S. Faraone,et al.  The Genetic Basis of Schizophrenia , 2004 .

[4]  D StClair,et al.  -141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. , 1999, American journal of medical genetics.

[5]  Yuhei Nakamura,et al.  Functional polymorphism of −141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia , 1998, Psychiatry Research.

[6]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[7]  R. Kerwin,et al.  Developments in the pharmacological treatment of schizophrenia , 2002, Expert opinion on investigational drugs.

[8]  N. Saitou,et al.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. , 2003, Human molecular genetics.

[9]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[10]  H. V. Van Tol,et al.  Polymorphisms in dopamine receptors: what do they tell us? , 2000, European journal of pharmacology.

[11]  G. Thaker,et al.  Advances in schizophrenia , 2001, Nature Medicine.

[12]  Markus M Nöthen,et al.  Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia , 1999, Schizophrenia Research.

[13]  T. Arinami,et al.  A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.

[14]  W. Stephan,et al.  The relationship between third-codon position nucleotide content, codon bias, mRNA secondary structure and gene expression in the drosophilid alcohol dehydrogenase genes Adh and Adhr. , 2001, Genetics.

[15]  S. Minoshima,et al.  Structure and expression of human and rat D2 dopamine receptor genes , 1992, Neurochemistry International.

[16]  S. Kapur,et al.  Half a century of antipsychotics and still a central role for dopamine D2 receptors , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  M. Kaneshima,et al.  An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population , 1997, Psychiatry and clinical neurosciences.

[18]  Laurent Gouya,et al.  The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia , 2004, Schizophrenia Research.

[19]  M. Gill,et al.  European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. , 1998, American journal of medical genetics.

[20]  M. Vares,et al.  Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta‐analysis , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  M C O'Donovan,et al.  The molecular genetics of schizophrenia: new findings promise new insights , 2004, Molecular Psychiatry.

[22]  Teresa Tallerico,et al.  Dopamine D2 receptor promoter polymorphism: no association with schizophrenia , 1999, Psychiatry Research.

[23]  P. Gorwood,et al.  Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. , 2001, Schizophrenia Research.

[24]  M. O’Donovan,et al.  Multicenter linkage study of schizophrenia loci on chromosome 22q , 2004, Molecular Psychiatry.

[25]  H. Akashi,et al.  Gene expression and molecular evolution. , 2001, Current opinion in genetics & development.

[26]  D. Weinberger.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[27]  H. Akashi,et al.  A test of translational selection at 'silent' sites in the human genome: base composition comparisons in alternatively spliced genes. , 2000, Gene.

[28]  H. Meltzer.  Biochemical studies in schizophrenia. , 1976, Schizophrenia bulletin.

[29]  J. Scharfetter.  Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update. , 2004, Pharmacogenomics.

[30]  J. Kennedy,et al.  Overview: Towards individualized treatment in schizophrenia , 2003 .

[31]  Peter McGuffin,et al.  Psychiatric Genetics and Genomics , 2002 .

[32]  M. Itokawa,et al.  Association of dopamine D2 receptor molecular variant with schizophrenia , 1994, The Lancet.

[33]  D. Grandy,et al.  Structure and linkage of the D2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23. , 1992, Genomics.

[34]  P. Riederer,et al.  Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder , 1998, Journal of Neural Transmission.

[35]  C. P. Morris,et al.  The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia , 2005, Schizophrenia Research.

[36]  Jeffrey A Lieberman,et al.  Recent advances in the neurobiology of schizophrenia. , 2003, Molecular interventions.

[37]  P. McGuffin,et al.  Genetic basis of schizophrenia , 1995, The Lancet.

[38]  A Carlsson,et al.  Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. , 2001, Annual review of pharmacology and toxicology.

[39]  R. Fukuda,et al.  Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia. , 1994, Biochemical and biophysical research communications.